Intensive speech treatment for patients with Parkinson's disease

The purpose of this study was to evaluate the long-term (12 months) effects of two forms of speech treatment on the speech and voice deficits that occur in Parkinson's disease. Thirty-five patients with idiopathic Parkinson's disease were assigned to one of two speech treatment groups: voice and respiration (The Lee Silverman Voice Treatment [LSVT]) or placebo (respiration) treatment. Vocal intensity data from before, immediately after, and at 6 and 12 months after speech treatment revealed statistically significant differences between the treatment groups. Only subjects in the LSVT group improved or maintained vocal intensity above pretreatment levels by 12 months after treatment. The placebo group had statistically significant deterioration of vocal intensity levels from before to 12 months after treatment during conversational monologue. The LSVT group did not deteriorate to levels below pretreatment in vocal intensity over the 12-month period. This study is the first to document the short- and long-term effects of intensive speech treatment (LSVT), which focuses on the voice, for patients with Parkinson's disease compared with a placebo speech treatment group. NEUROLOGY 1996;47: 1496-1504

[1]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[2]  L. Ramig,et al.  Aerodynamic mechanisms underlying treatment-related changes in vocal intensity in patients with Parkinson disease. , 1996, Journal of speech and hearing research.

[3]  L. Ramig,et al.  The Parkinson larynx: tremor and videostroboscopic findings. , 1996, Journal of voice : official journal of the Voice Foundation.

[4]  L. Ramig,et al.  Intensive voice treatment in Parkinson disease: laryngostroboscopic findings. , 1995, Journal of voice : official journal of the Voice Foundation.

[5]  S. Countryman,et al.  Comparison of two forms of intensive speech treatment for Parkinson disease. , 1995, Journal of speech and hearing research.

[6]  Lorraine O. Ramig,et al.  The Lee Silverman Voice Treatment: A Practical Guide to Treating the Voice and Speech Disorders in Parkinson’s Disease , 1995 .

[7]  L. Raming,et al.  Voice treatment for patients with Parkinson desease: Development of an approach and preliminary efficacy data , 1994 .

[8]  G. Stelmach,et al.  Control of stroke size, peak acceleration, and stroke duration in Parkinsonian handwriting , 1991 .

[9]  Stephen Grossberg,et al.  Adaptive neural networks for control of movement trajectories invariant under speed and force rescaling , 1991 .

[10]  G. Stelmach,et al.  SCALING PROBLEMS IN PARKINSON'S DISEASE , 1991 .

[11]  G. Stelmach.  Basal Ganglia Impairment and Force Control , 1991 .

[12]  G. Stelmach,et al.  Tutorials in motor neuroscience , 1991 .

[13]  L. Leinonen,et al.  Control of static pressure by expiratory muscles during expiratory effort and phonation , 1990 .

[14]  K. Lyons,et al.  Therapy of Parkinson's disease , 1990 .

[15]  W. Weiner,et al.  Parkinson's Disease and Nonpharmacologic Treatment Programs , 1989, Journal of the American Geriatrics Society.

[16]  Renata Whurr,et al.  Clinical Management of Dysarthric Speakers , 1988 .

[17]  P. Milenkovic,et al.  Least mean square measures of voice perturbation. , 1987, Journal of speech and hearing research.

[18]  S. Fahn.  Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[19]  S. Fahn.  Unified Parkinson's Disease Rating Scale , 1987 .

[20]  J. Kehne.  The Neural Basis of Motor Control , 1987, The Yale Journal of Biology and Medicine.

[21]  M. Picheny,et al.  Speaking clearly for the hard of hearing. II: Acoustic characteristics of clear and conversational speech. , 1986, Journal of speech and hearing research.

[22]  S. Gandevia,et al.  Strength and endurance of inspiratory, expiratory, and limb muscles in asthma. , 1986, The American review of respiratory disease.

[23]  A W Downie,et al.  Parkinson's disease: disability, review, and management. , 1986, British medical journal.

[24]  R. Beaglehole,et al.  Cigarette smoking and risk of premature stroke in men and women. , 1986, British medical journal.

[25]  J. A. Adams.  Use of the model's knowledge of results to increase the observer's performance , 1986 .

[26]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[27]  M. Streifler,et al.  Disorders of verbal expression in parkinsonism. , 1984, Advances in neurology.

[28]  F. Caird,et al.  Speech therapy for patients with Parkinson's disease. , 1981, British medical journal.

[29]  M. Bergner,et al.  The Sickness Impact Profile: Development and Final Revision of a Health Status Measure , 1981, Medical care.

[30]  M. Hallett,et al.  A physiological mechanism of bradykinesia. , 1980, Brain : a journal of neurology.

[31]  R Netsell,et al.  Dysarthria in adults: physiologic approach to rehabilitation. , 1979, Archives of physical medicine and rehabilitation.

[32]  G. Chelune,et al.  Using neuropsychological and personality tests to assess the likelihood of patient employment. , 1978, The Journal of nervous and mental disease.

[33]  J. Logemann,et al.  Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. , 1978, The Journal of speech and hearing disorders.

[34]  R. Schmidt.  A schema theory of discrete motor skill learning. , 1975 .

[35]  I. T. Draper.  THE ASSESSMENT OF APHASIA AND RELATED DISORDERS , 1973 .

[36]  J. Adams,et al.  A closed-loop theory of motor learning. , 1971, Journal of motor behavior.

[37]  C. M. Allan.  Treatment of non fluent speech resulting from neurological disease--treatment of dysarthria. , 1970, The British journal of disorders of communication.

[38]  A. Aronson,et al.  Clusters of deviant speech dimensions in the dysarthrias. , 1969, Journal of speech and hearing research.

[39]  A. Aronson,et al.  Differential diagnostic patterns of dysarthria. , 1969, Journal of speech and hearing research.

[40]  M T Sarno,et al.  Speech impairment in Parkinson's disease. , 1968, Archives of physical medicine and rehabilitation.

[41]  Edith Whetnall,et al.  Book Review: Principles of Bone X-ray Diagnosis , 1965 .

[42]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[43]  G. Fairbanks.  Voice and articulation drillbook , 1960 .

[44]  R. Schwab,et al.  The management of Parkinson's disease. , 1959, Archives of internal medicine.

[45]  W. J. Martin,et al.  Cryptococcosis: further observations and experiences with amphotericin B. , 1959, A.M.A. archives of internal medicine.

[46]  M. Greene,et al.  The voice and its disorders , 1957 .

[47]  J. M. Pickett,et al.  Effects of Vocal Force on the Intelligibility of Speech Sounds , 1956 .

[48]  D. A. Weiss,et al.  A method of therapy for paralytic conditions of the mechanisms of phonation, respiration and glutination. , 1955, The Journal of speech and hearing disorders.

[49]  D. Morley.  The rehabilitation of adults with dysarthric speech. , 1955, The Journal of speech and hearing disorders.